TrialHead & neck2019

Randomized phase II/III confirmatory treatment selection design with a change of survival end points: Statistical design of Radiation Therapy Oncology Group 1216.

Qiang Ed Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.